Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Brugada syndrome].

T Veiser1, G Laurent, J E Wolf

  • 1IV interní klinika 1, LF UK a VFN, Praha. veissman@atlas.cz

Casopis Lekaru Ceskych
|June 11, 2005
PubMed
Summary
This summary is machine-generated.

Brugada syndrome, a genetic heart condition, causes sudden cardiac death in 4-12% of cases. Effective treatment involves implanting a cardiverter-defibrillator.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM).

Journal de mycologie medicale·2024
Same author

Factors associated with patent foramen ovale-related stroke: SAFAS study.

Revue neurologique·2023
Same author

Consistency of species ranking based on functional leaf traits.

The New phytologist·2022
Same author

Pigmentation effects of blue light irradiation on skin and how to protect against them.

International journal of cosmetic science·2020
Same author

Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology (SFC) and the Société française d'imagerie cardiaque et vasculaire diagnostique et interventionnelle (SFICV) on magnetic resonance imaging in patients with cardiac electronic implantable devices.

Diagnostic and interventional imaging·2020
Same author

AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study.

BMC cancer·2019
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Context:

  • Brugada syndrome is a distinct clinical entity associated with a high risk of sudden cardiac death.
  • It accounts for 4-12% of all sudden deaths and 20% of deaths in individuals with structurally normal hearts.
  • First described in 1992, it presents with ST segment elevation in right precordial leads (V1-V3) unrelated to ischemia or electrolyte disturbances.

Purpose:

  • To summarize the key characteristics, genetic basis, and management of Brugada syndrome.
  • To highlight the diagnostic challenges and therapeutic options for this condition.

Summary:

  • Brugada syndrome is characterized by ECG findings (dynamic ST segment elevation) and clinical manifestations including syncope or sudden death.
  • The underlying arrhythmia is rapid polymorphic ventricular tachycardia, often triggered by concealed or unmasked ECG abnormalities.

Related Experiment Videos

  • Genetic linkage to SCNA5 mutations, encoding the sodium channel alpha subunit, points to a familial autosomal dominant inheritance pattern with incomplete penetrance.

    • Impact:

    • Understanding Brugada syndrome is crucial for identifying individuals at risk of sudden cardiac death.
    • Early diagnosis and appropriate management, such as automatic cardiverter-defibrillator implantation, can prevent fatal arrhythmias.
    • Further research into SCNA5 mutations and therapeutic strategies may improve patient outcomes.